BioMarin Pharmaceuticals
BMRN
BMRN
377 hedge funds and large institutions have $19.5B invested in BioMarin Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 148 increasing their positions, 110 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
377
Holders Change
+36
Holders Change %
+10.56%
% of All Funds
10.06%
Holding in Top 10
16
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+45.45%
% of All Funds
0.43%
New
77
Increased
148
Reduced
110
Closed
37
Calls
$218M
Puts
$240M
Net Calls
-$21.5M
Net Calls Change
-$78.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$777M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$178M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$146M |
| 4 |
JPMorgan Chase & Co
New York
|
+$124M |
| 5 |
SC
Sculptor Capital
New York
|
+$74.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$193M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$125M |
| 3 |
TG
TCW Group
Los Angeles,
California
|
-$113M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$87.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$61.4M |
